Legend Biotech (LEGN) Stock Price, Quote, News & History | Benzinga

Legend Biotech Corp (LEGN) Stock Price, Quote, News & History

LEGNNASDAQ

Trade with Public

Trade with Public

$21.26

-1.34-5.93%

At close: Aug 19, 5:00 PM EST

$21.50

-1.10-4.85%

Pre-Market: 7:36 AM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

-

Close

$21.26

Volume / Avg.

3.96K / 2.75M

Day Range

- - -

52 Wk Range

16.24 - 37.50

Market Cap

$4.18B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

48

Short Interest

22.02%

Days to Cover

6.04

Recent Legend Biotech Corporation News

This Apogee Therapeutics Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

Analysts changed outlooks on top stocks. Raymond James downgraded ONON, Deutsche Bank downgraded ATAI, BTIG downgraded APGE.

Avi Kapoor

Top 3 Health Care Stocks You'll Regret Missing This Quarter

The most oversold health care stocks present a buying opportunity. RSI indicator compares stock strength on up and down days, indicating short-term performance. Here's the latest list of oversold players in this sector.

Avi Kapoor

Top 3 Health Care Stocks That May Rocket Higher In July

Health care sector oversold - buying opportunities in undervalued companies. RSI compares stock strength on up/down days, below 30 is oversold.

Avi Kapoor

Why Is Legend Biotech Stock Falling Thursday?

Legend Biotech (LEGN) shares drop in premarket trading after pricing a $226M public offering. Get the latest technical levels here.

Vandana Singh

Legend Biotech, Sleep Number And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

US stock futures up, Nasdaq futures 1% higher. Legend Biotech (LEGN) priced 7.7 million ADSs at $29.35 each, shares down 9% in pre-market trading.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-89.40M

Investing Cash Flow (TTM)

330.50M

Financing Cash Flow (TTM)

166.50M

Free Cash Flow (TTM)

-121.80M

Capital Expenditure (TTM)

-32.40M

Net Change in Cash (TTM)

407.60M

Analyst Trends and Forecast

3

May

2

Jun

3

2

Jul

3

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$3.45B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

3.10

PB Ratio (TTM)

3.36

Earnings Yield % (TTM)

-2.35%

Earnings Yield % (FWD)

-0.19%

EV / EBITDA (TTM)

300.03

Price / EBITDA (TTM)

342.85

Price / Free Cash Flow (TTM)

-

Book Value / Share

$6.32

Company Debt

Total Debt

$156.40M

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$47.80M

Total Cash

$672.90M

Debt to Equity

0.23

Issuance of Debt (TTM)

-$47.80M

Repayment of Debt (TTM)

-$47.80M

Key Statistics

Open

-

Close

$21.26

Volume / Avg.

3.96K / 2.75M

Day Range

- - -

52 Wk Range

16.24 - 37.50

Market Cap

$4.18B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

48

Short Interest

22.02%

Days to Cover

6.04

About

Sector

Health Care

Industry

Biotechnology

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen rece...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Legend Biotech (LEGN) stock?

A

You can purchase shares of Legend Biotech (NASDAQ:LEGN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Legend Biotech (LEGN) competitors?

A

Other companies in Legend Biotech’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Legend Biotech (LEGN) stock?

A

Legend Biotech has a consensus price target of $64.60.

Q

What is the current price for Legend Biotech (LEGN)?

A

The stock price for Legend Biotech (NASDAQ: LEGN) is $21.505 last updated August 21, 2026 at 7:11 AM EDT.

Q

Does Legend Biotech (LEGN) pay a dividend?

A

There are no upcoming dividends for Legend Biotech.

Q

When is Legend Biotech (NASDAQ:LEGN) reporting earnings?

A

Legend Biotech does not have any upcoming earnings scheduled.

Q

Is Legend Biotech (LEGN) going to split?

A

There is no upcoming split for Legend Biotech.

Q

What sector and industry does Legend Biotech (LEGN) operate in?

A

Legend Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.